









市場行情
/
股票
/
nasdaq-rvty
/

Revvity Inc

RVTY

96.200USD

-0.060-0.06%

收盤 12/19, 16:00（美東）報價延遲15分鐘

10.97B總市值

48.35本益比TTM



Revvity Inc

96.200

-0.060-0.06%

概覽公司財務分析

概覽

公司

財務

分析

關於 Revvity Inc 公司

Revvity, Inc. is a provider of health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. The Company has specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. Its segments include Life Sciences and Diagnostics. The Life Sciences segment provides products and services targeted towards the life sciences market. The segment offers instruments, reagents, software, detection and imaging technologies, and others. The Diagnostics segment develops diagnostics, tools, and applications focused on clinically oriented customers, within the reproductive health, immunodiagnostics, and applied genomics markets. The segment offers instruments, reagents, assay platforms and software to hospitals, medical labs, clinicians and medical research professionals to help improve the health of families.

Revvity Inc簡介



公司代碼RVTY

公司名稱Revvity Inc

上市日期Aug 12, 2101

CEOSingh (Prahlad R)

員工數量11000

證券類型Ordinary Share

年結日Aug 12

公司地址77 4Th Avenue

城市WALTHAM

上市交易所NASDAQ OMX NASDAQ Basic NYSE

國家United States of America

郵編02451

電話17816636900

網址https://www.revvity.com/

公司代碼RVTY

上市日期Aug 12, 2101

CEOSingh (Prahlad R)

Revvity Inc公司高管



名稱

名稱/職務

職務

持股

持股變動

Dr. Prahlad R. Singh, Ph.D.

President, Chief Executive Officer, Director

96.84K

-8.87%

Mr. Alexandros P. (Alexis) Michas

Independent Non-Executive Chairman of the Board

45.44K

+6.67%

Mr. Joel S. Goldberg

Senior Vice President - Administration, General Counsel, Secretary

37.69K

+12.84%

Dr. Peter Barrett, Ph.D.

Independent Director

26.01K

+10.22%

Mr. Maxwell Krakowiak

Chief Financial Officer, Senior Vice President

22.80K

-2.39%

Ms. Miriame Victor

Chief Commercial Officer, Senior Vice President

14.29K

+61.74%

Ms. Pascale Witz

Independent Director

13.71K

+21.36%

Mr. Tajinder S. Vohra

Senior Vice President - Global Operations

10.44K

-53.85%

Mr. Michael A. Klobuchar

Independent Director

5.09K

+90.13%

Dr. Sophie V. Vandebroek, Ph.D.

Independent Director

5.09K

+90.13%

名稱

名稱/職務

職務

持股

持股變動

Dr. Prahlad R. Singh, Ph.D.

President, Chief Executive Officer, Director

96.84K

-8.87%

Mr. Alexandros P. (Alexis) Michas

Independent Non-Executive Chairman of the Board

45.44K

+6.67%

Mr. Joel S. Goldberg

Senior Vice President - Administration, General Counsel, Secretary

37.69K

+12.84%

Dr. Peter Barrett, Ph.D.

Independent Director

26.01K

+10.22%

Mr. Maxwell Krakowiak

Chief Financial Officer, Senior Vice President

22.80K

-2.39%

Ms. Miriame Victor

Chief Commercial Officer, Senior Vice President

14.29K

+61.74%

收入明細

單位: USD更新時間: 10月6日週一

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

FY2018

業務USD

名稱

營收

佔比

Product

610.70M

84.79%

Service

109.58M

15.21%

地區USD

名稱

營收

佔比

Americas

323.58M

44.92%

Europe

203.63M

28.27%

Asia

193.07M

26.80%

業務

地區

業務USD

名稱

營收

佔比

Product

610.70M

84.79%

Service

109.58M

15.21%

股東統計

更新時間: 11月17日週一

持股股東

股東類型

持股股東

佔比

T. Rowe Price Investment Management, Inc.

19.85%

The Vanguard Group, Inc.

11.88%

EdgePoint Investment Group Inc.

7.56%

T. Rowe Price Associates, Inc.

7.05%

Janus Henderson Investors

6.73%

其他

46.93%

持股股東

佔比

T. Rowe Price Investment Management, Inc.

19.85%

The Vanguard Group, Inc.

11.88%

EdgePoint Investment Group Inc.

7.56%

T. Rowe Price Associates, Inc.

7.05%

Janus Henderson Investors

6.73%

其他

46.93%

股東類型

持股股東

佔比

Investment Advisor

70.04%

Investment Advisor/Hedge Fund

25.98%

Hedge Fund

2.79%

Pension Fund

1.77%

Research Firm

1.69%

Sovereign Wealth Fund

1.18%

Bank and Trust

1.07%

Individual Investor

0.30%

Family Office

0.05%

機構持股



更新時間: 10月1日週三

報告期間

機構數

持股數

持股佔比

持股變動

2025Q3

1177

117.06M

100.85%

-8.83M

2025Q2

1199

113.79M

98.03%

-7.04M

2025Q1

1255

117.73M

99.83%

-3.82M

2024Q4

1277

114.54M

95.28%

-3.97M

2024Q3

1253

112.35M

91.11%

-5.77M

2024Q2

1249

112.44M

91.13%

-1.63M

2024Q1

1287

107.57M

87.09%

-8.24M

2023Q4

1315

109.29M

88.55%

-2.41M

2023Q3

1347

106.10M

85.47%

-6.10M

2023Q2

1383

106.88M

85.21%

-9.65M

股東持股明細



名稱

持股數

佔比

持股變動

變動比例

公告日期

T. Rowe Price Investment Management, Inc.

22.64M

19.51%

+126.19K

+0.56%

Jun 30, 2025

The Vanguard Group, Inc.

14.03M

12.09%

-297.65K

-2.08%

Jun 30, 2025

EdgePoint Investment Group Inc.

6.79M

5.85%

+1.43M

+26.65%

Jun 30, 2025

T. Rowe Price Associates, Inc.

7.80M

6.72%

-1.59M

-16.90%

Jun 30, 2025

Janus Henderson Investors

7.22M

6.22%

+1.23M

+20.47%

Jun 30, 2025

BlackRock Institutional Trust Company, N.A.

5.81M

-259.62K

-4.28%

Jun 30, 2025

State Street Investment Management (US)

5.02M

4.32%

-150.58K

-2.91%

Jun 30, 2025

Geode Capital Management, L.L.C.

2.98M

2.56%

-18.52K

-0.62%

Jun 30, 2025

Invesco Capital Management LLC

1.94M

1.67%

+422.41K

+27.88%

Jun 30, 2025

UBS Financial Services, Inc.

1.75M

1.51%

+1.12M

+178.25%

Jun 30, 2025

持股ETF



更新時間: 12月6日週六

機構名稱

佔比

First Trust Indxx Medical Devices ETF

2.12%

Invesco S&P 500 Equal Weight Health Care ETF

1.85%

T Rowe Price Capital Appreciation Equity ETF

1.36%

Simplify Health Care ETF

1.29%

ROBO Global Healthcare Technology & Innovation ETF

1.16%

First Trust Health Care Alphadex Fund

0.93%

Pacer CFRA-Stovall Equal Weight Seasonal Rot Idx

0.84%

VanEck Morningstar SMID Moat ETF

0.64%

Neuberger Berman Small-Mid Cap ETF

0.56%

NYLI Candriam US Mid Cap Equity ETF

0.5%

First Trust Indxx Medical Devices ETF

佔比2.12%

Invesco S&P 500 Equal Weight Health Care ETF

佔比1.85%

T Rowe Price Capital Appreciation Equity ETF

佔比1.36%

Simplify Health Care ETF

佔比1.29%

ROBO Global Healthcare Technology & Innovation ETF

佔比1.16%

First Trust Health Care Alphadex Fund

佔比0.93%

Pacer CFRA-Stovall Equal Weight Seasonal Rot Idx

佔比0.84%

VanEck Morningstar SMID Moat ETF

佔比0.64%

Neuberger Berman Small-Mid Cap ETF

佔比0.56%

NYLI Candriam US Mid Cap Equity ETF

佔比0.5%

分紅派息



近5年累計派現 168.35M 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

Oct 23, 2025

RVTY.NB Final Cash Dividend of gross USD 0.07 paid on Feb 06, 2026 going ex on Jan 16, 2026

Jan 16, 2026

Feb 06, 2026

Jan 16, 2026

Jul 24, 2025

RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on Nov 07, 2025 going ex on Oct 17, 2025

Oct 17, 2025

Nov 07, 2025

Oct 17, 2025

Apr 24, 2025

RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on Aug 08, 2025 going ex on Jul 18, 2025

Jul 18, 2025

Aug 08, 2025

Jul 18, 2025

Jan 23, 2025

RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on May 09, 2025 going ex on Apr 17, 2025

Apr 18, 2025

May 09, 2025

Apr 17, 2025

Oct 24, 2024

RVTY.NB Final Cash Dividend of gross USD 0.07 paid on Feb 07, 2025 going ex on Jan 17, 2025

Jan 17, 2025

Feb 07, 2025

Jan 17, 2025

Jul 25, 2024

RVTY.NB Final Cash Dividend of gross USD 0.07 paid on Nov 08, 2024 going ex on Oct 18, 2024

Oct 18, 2024

Nov 08, 2024

Oct 18, 2024

Apr 25, 2024

RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on Aug 09, 2024 going ex on Jul 19, 2024

Jul 19, 2024

Aug 09, 2024

Jul 19, 2024

Jan 25, 2024

RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on May 10, 2024 going ex on Apr 18, 2024

Apr 19, 2024

May 10, 2024

Apr 18, 2024

Oct 26, 2023

RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on Feb 09, 2024 going ex on Jan 18, 2024

Jan 19, 2024

Feb 09, 2024

Jan 18, 2024

Jul 21, 2023

RVTY.NB Final Cash Dividend of gross USD 0.07 paid on Nov 10, 2023 going ex on Oct 19, 2023

Oct 20, 2023

Nov 10, 2023

Oct 19, 2023

拆合股



公告日期

類型

比率

暫無數據

公告日期

類型

比率

暫無數據

常見問題

Revvity Inc的前五大股東是誰？



Revvity Inc的前五大股東如下：
T. Rowe Price Investment Management, Inc.
持有股份：22.64M
佔總股份比例：19.51%。
The Vanguard Group, Inc.
持有股份：14.03M
佔總股份比例：12.09%。
EdgePoint Investment Group Inc.
持有股份：6.79M
佔總股份比例：5.85%。
T. Rowe Price Associates, Inc.
持有股份：7.80M
佔總股份比例：6.72%。
Janus Henderson Investors
持有股份：7.22M
佔總股份比例：6.22%。